Association between psychopharmacotherapy and postpartum hemorrhage
Frank I Jackson1,2,3, Insaf Kouba1,2,3, Natalie Meirowitz1,3,4
1Northwell, New Hyde Park, NY (Jackson, Kouba, Meirowitz, Keller, Bracero, and Blitz).
AJOG Global Reports
|November 8, 2024
Summary
Prenatal psychopharmacotherapy (PPT) use is linked to a higher risk of postpartum hemorrhage (PPH) requiring transfusion. Combination PPT therapy showed a greater association with PPH than monotherapy.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Mental Health
- Pharmacology
Background:
- Inconsistent findings exist regarding the link between psychopharmacotherapy (PPT) and postpartum hemorrhage (PPH).
- Clarifying this relationship is crucial for patient counseling and risk assessment.
- This study investigates the association between prenatal PPT exposure and PPH requiring transfusion.
Purpose of the Study:
- To evaluate the association between prenatal PPT exposure and PPH requiring packed red blood cell transfusion (PPH+pRBC).
- To examine the link between individual PPT drug classes and PPH+pRBC.
- To assess the association between mental health treatment intensity and PPH+pRBC.
Main Methods:
- Retrospective cross-sectional study of 107,425 deliveries between January 2019 and December 2022.
- Analysis of prenatal exposure to various psychotropic medications, including SSRIs, SNRIs, benzodiazepines, and others.
- Multivariable logistic regression adjusted for known hemorrhage risk factors.
Main Results:
- Prenatal PPT exposure occurred in 3.6% of pregnancies, with a PPH+pRBC rate of 5.5% compared to 2.8% in unexposed pregnancies (aOR 2.10).
- SSRIs and benzodiazepine monotherapy were associated with increased PPH+pRBC odds.
- Combination PPT was linked to significantly higher odds of PPH+pRBC (aOR 3.96) compared to monotherapy and no PPT use.
Conclusions:
- Prenatal psychopharmacotherapy exposure is associated with increased odds of clinically significant postpartum hemorrhage requiring transfusion.
- Combination therapy demonstrated a stronger association with PPH+pRBC compared to monotherapy.
- These findings underscore the importance of careful risk-benefit assessment for pregnant individuals using psychotropic medications.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Psychosis and Antipsychotic Drugs: Overview
179
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
179
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
87
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
87
Antidepressant Drugs: MAOIs and Other Agents
195
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
195
Mania and Antimanic Drugs: Overview
136
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
136


